Cargando…

Three novel obese indicators perform better in monitoring management of metabolic syndrome in type 2 diabetes

The present study evaluated the performance of three novel obese indicators, visceral adiposity index (VAI), lipid accumulation product (LAP) and waist circumference-triglyceride index (WTI), for identifying metabolic syndrome(MetS) in type 2 diabetes. A cross-sectional study was conducted on 711 ty...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Chun-Ming, Lu, Na, Wang, Rui, Liu, Xiao-Li, Lu, Qiang, Yin, Fu-Zai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574991/
https://www.ncbi.nlm.nih.gov/pubmed/28852155
http://dx.doi.org/10.1038/s41598-017-10446-3
_version_ 1783259946578608128
author Ma, Chun-Ming
Lu, Na
Wang, Rui
Liu, Xiao-Li
Lu, Qiang
Yin, Fu-Zai
author_facet Ma, Chun-Ming
Lu, Na
Wang, Rui
Liu, Xiao-Li
Lu, Qiang
Yin, Fu-Zai
author_sort Ma, Chun-Ming
collection PubMed
description The present study evaluated the performance of three novel obese indicators, visceral adiposity index (VAI), lipid accumulation product (LAP) and waist circumference-triglyceride index (WTI), for identifying metabolic syndrome(MetS) in type 2 diabetes. A cross-sectional study was conducted on 711 type 2 diabetes in Qinhuangdao. The MetS was defined as the definition of Chinese Diabetes Society. Receiver operating characteristic curve analyses were performed to assess the accuracy of three obese indicators as diagnostic tests for MetS. The prevalence of MetS was 71.3%. In men, among all three obese indicators, the LAP had the highest area under curve (AUC) value (AUC = 0.894), followed by VAI (AUC = 0.860) and WTI (AUC = 0.855). In women, among all three obese indicators, the LAP had the highest AUC value (AUC = 0.906), followed by WTI (AUC = 0.887) and VAI (AUC = 0.881). However. there was no significant difference between the three obese indicators(P > 0.05). Three obese indicators were effective indicators for the screening of MetS, LAP and WTI are more simple.
format Online
Article
Text
id pubmed-5574991
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-55749912017-09-01 Three novel obese indicators perform better in monitoring management of metabolic syndrome in type 2 diabetes Ma, Chun-Ming Lu, Na Wang, Rui Liu, Xiao-Li Lu, Qiang Yin, Fu-Zai Sci Rep Article The present study evaluated the performance of three novel obese indicators, visceral adiposity index (VAI), lipid accumulation product (LAP) and waist circumference-triglyceride index (WTI), for identifying metabolic syndrome(MetS) in type 2 diabetes. A cross-sectional study was conducted on 711 type 2 diabetes in Qinhuangdao. The MetS was defined as the definition of Chinese Diabetes Society. Receiver operating characteristic curve analyses were performed to assess the accuracy of three obese indicators as diagnostic tests for MetS. The prevalence of MetS was 71.3%. In men, among all three obese indicators, the LAP had the highest area under curve (AUC) value (AUC = 0.894), followed by VAI (AUC = 0.860) and WTI (AUC = 0.855). In women, among all three obese indicators, the LAP had the highest AUC value (AUC = 0.906), followed by WTI (AUC = 0.887) and VAI (AUC = 0.881). However. there was no significant difference between the three obese indicators(P > 0.05). Three obese indicators were effective indicators for the screening of MetS, LAP and WTI are more simple. Nature Publishing Group UK 2017-08-29 /pmc/articles/PMC5574991/ /pubmed/28852155 http://dx.doi.org/10.1038/s41598-017-10446-3 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Ma, Chun-Ming
Lu, Na
Wang, Rui
Liu, Xiao-Li
Lu, Qiang
Yin, Fu-Zai
Three novel obese indicators perform better in monitoring management of metabolic syndrome in type 2 diabetes
title Three novel obese indicators perform better in monitoring management of metabolic syndrome in type 2 diabetes
title_full Three novel obese indicators perform better in monitoring management of metabolic syndrome in type 2 diabetes
title_fullStr Three novel obese indicators perform better in monitoring management of metabolic syndrome in type 2 diabetes
title_full_unstemmed Three novel obese indicators perform better in monitoring management of metabolic syndrome in type 2 diabetes
title_short Three novel obese indicators perform better in monitoring management of metabolic syndrome in type 2 diabetes
title_sort three novel obese indicators perform better in monitoring management of metabolic syndrome in type 2 diabetes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574991/
https://www.ncbi.nlm.nih.gov/pubmed/28852155
http://dx.doi.org/10.1038/s41598-017-10446-3
work_keys_str_mv AT machunming threenovelobeseindicatorsperformbetterinmonitoringmanagementofmetabolicsyndromeintype2diabetes
AT luna threenovelobeseindicatorsperformbetterinmonitoringmanagementofmetabolicsyndromeintype2diabetes
AT wangrui threenovelobeseindicatorsperformbetterinmonitoringmanagementofmetabolicsyndromeintype2diabetes
AT liuxiaoli threenovelobeseindicatorsperformbetterinmonitoringmanagementofmetabolicsyndromeintype2diabetes
AT luqiang threenovelobeseindicatorsperformbetterinmonitoringmanagementofmetabolicsyndromeintype2diabetes
AT yinfuzai threenovelobeseindicatorsperformbetterinmonitoringmanagementofmetabolicsyndromeintype2diabetes